G
George Morgan
Researcher at Imperial College London
Publications - 5
Citations - 27
George Morgan is an academic researcher from Imperial College London. The author has contributed to research in topics: Tuberculosis & Medicine. The author has an hindex of 1, co-authored 3 publications receiving 10 citations.
Papers
More filters
Journal ArticleDOI
Global optometrist top 200 research ranking
TL;DR: The primary evidence for which is publications in refereed scientific journals is a rigorous research base, which is underpinned by a rigorous clinical optometric practice as discussed by the authors, which is the primary evidence which is used for clinical optometrists who...
Journal ArticleDOI
Real-time imaging and analysis of cell-hydrogel interplay within an extrusion-bioprinting capillary
Gowsihan Poologasundarampillai,Abdelrahman Haweet,Abdelrahman Haweet,Soher Nagi Jayash,George Morgan,James E. Moore,Alessia Candeo,Alessia Candeo +7 more
TL;DR: Direct observations of the hydrogels and suspended cells during the printing process are presented to help elucidate conditions potentially leading to mechanical damage and cell death and improve modeling cell-material flow during bioprinting through accurate estimation of flow conditions, in particular for complex materials.
Journal ArticleDOI
Mechanism of Actuation in Nickel Hydroxide/Oxyhydroxide Photoactuators
Journal ArticleDOI
Microfluidic Capture of Mycobacterium tuberculosis from Clinical Samples for Culture-Free Whole-Genome Sequencing
Nabila Ismail,Anzaan Dippenaar,George Morgan,Melanie Grobbelaar,Felicia Wells,Jessica Caffry,Krzysztof Gizynski,David McGurk,Heather E. Murton,Robin M. Warren,Annelies Van Rie +10 more
TL;DR: In this article , the use of Capture-XT, a microfluidic lab-on-chip cleanup and pathogen concentration platform, was used to enrich M. tuberculosis bacilli from clinical sputum specimens for downstream DNA extraction and whole-genome sequencing (WGS).
Journal ArticleDOI
A Novel Microfluidic Dielectrophoresis Technology to Enable Rapid Diagnosis of Mycobacteria tuberculosis in Clinical Samples.
Catherine Moore,Jasvir Dhillon,Krzysztof Gizynski,George Morgan,David McGurk,S. Basir Shabestary,Jonathan O’Halloran,Neil G. Stoker,Philip D. Butcher,Heather E. Murton +9 more
TL;DR: In this article , the authors used the CAPTURE-XT technology to provide a powerful sample preparation tool that could function as a front-end platform for molecular detection, which could be applied as a visual detection diagnostic, potentially associated with bacterial identification for low-cost screening or coupled with an expanded PCR assay for genotypic drug susceptibility testing.